PEMBROLIZUMAB , Matching placebo, EIK1001 solution for injection 1.0 mg/mL free base equivalent
EIK1001-006
Phase 3 small_molecule active
Quick answer
PEMBROLIZUMAB , Matching placebo, EIK1001 solution for injection 1.0 mg/mL free base equivalent for Advanced Melanoma is a Phase 3 program (small_molecule) at Eikon Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eikon Therapeutics
- Indication
- Advanced Melanoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active